| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8228520 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 7 Pages |
Abstract
Stereotactic body radiotherapy is safe and promising as a radical treatment for operable Stage I NSCLC. The survival rate for SBRT is potentially comparable to that for surgery.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Hiroshi M.D., Hiroki M.D., Yasushi M.D., Masahiro M.D., Masaharu M.D., Kotaro M.D., Katsuyuki M.D., Kazushige M.D., Yuzuru M.D., Yoshihiro M.D., Tomoki M.D., Atsuya M.D., Atsushi M.D., Masato M.D., Masaki M.D., Takuyo M.D., Takuro M.D., Ryusuke M.D.,